Literature DB >> 35462733

Chicago Classification Version 4.0 and Its Impact on Current Clinical Practice.

Joel E Richter1.   

Abstract

High-resolution manometry (HRM) has revolutionized esophageal motility testing, and the evolving Chicago Classification has been critical in codifying HRM metrics and definitions of old and new motility disorders. The latest Chicago Classification (version 4.0) is the result of a working group of 52 members (10 women) from 20 countries. Two critical new elements are the expansion of the normal database from 75 to 469 healthy volunteers and the recommendation of ancillary function tests (timed barium esophagram, functional lumen imaging planimetry, and/or impedance) to help with inconclusive HRM metrics, especially in cases of suspected achalasia, esophagogastric junction outflow obstruction (EGJOO), and ineffective esophageal motility (IEM). Important changes relevant to clinical practice include (1) refinement of the diagnosis criteria for EGJOO, which now require elevated integrated relaxation pressure in an upright position along with primary symptoms of dysphagia/noncardiac chest pain and obstruction at the esophago-gastric junction; (2) exclusion of mechanical obstruction in cases of suspected distal esophageal spasm and hypercontractile esophagus; and (3) a shift to a more restrictive metric (>70% ineffective peristalsis) for a diagnosis of IEM. In addition, the working group urged caution in using treatments such as pneumatic dilation or myotomy, which can irreversibly destroy lower esophageal sphincter competency and peristalsis, as the natural history of EGJOO/hypercontractile esophagus is poorly understood and spontaneous symptom resolution is common. Future versions should address the routine use of impedance with HRM, the role of HRM in pharyngeal/upper esophageal sphincter diseases, and the need for better criteria to determine which subsets of spastic disorders warrant aggressive treatment, as is done with achalasia.
Copyright © 2021, Gastro-Hep Communications, Inc.

Entities:  

Keywords:  Chicago Classification; High-resolution manometry; absent contractility; achalasia; diffuse esophageal spasm; esophagogastric junction outflow obstruction; hypercontractile esophagus; ineffective esophageal motility

Year:  2021        PMID: 35462733      PMCID: PMC9021169     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  47 in total

1.  Endogenous nitric oxide in the control of esophageal motility in humans.

Authors:  J W Konturek; P Thor; A Lukaszyk; A Gabryelewicz; S J Konturek; W Domschke
Journal:  J Physiol Pharmacol       Date:  1997-06       Impact factor: 3.011

2.  Quantifying esophageal peristalsis with high-resolution manometry: a study of 75 asymptomatic volunteers.

Authors:  Sudip K Ghosh; John E Pandolfino; Qing Zhang; Andrew Jarosz; Nimeesh Shah; Peter J Kahrilas
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-01-12       Impact factor: 4.052

3.  Distal contraction latency: a measure of propagation velocity optimized for esophageal pressure topography studies.

Authors:  Sabine Roman; Zhiyue Lin; John E Pandolfino; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2010-10-26       Impact factor: 10.864

4.  Jackhammer esophagus with and without esophagogastric junction outflow obstruction demonstrates altered neural control resembling type 3 achalasia.

Authors:  Farhan Quader; Aurelio Mauro; Edoardo Savarino; Salvatore Tolone; Nicola de Bortoli; Marianna Franchina; Matteo Ghisa; Krista Edelman; Lokesh K Jha; Roberto Penagini; C Prakash Gyawali
Journal:  Neurogastroenterol Motil       Date:  2019-07-16       Impact factor: 3.598

5.  Hypercontractile Esophagus From Pathophysiology to Management: Proceedings of the Pisa Symposium.

Authors:  Nicola de Bortoli; Prakash Chandra Gyawali; Sabine Roman; Salvatore Tolone; Daniel Sifrim; Radu Tutuian; Roberto Penagini; John Erik Pandolfino; Edoardo Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2020-12-03       Impact factor: 10.864

Review 6.  High-Resolution Pharyngeal Manometry and Impedance: Protocols and Metrics-Recommendations of a High-Resolution Pharyngeal Manometry International Working Group.

Authors:  Taher I Omari; Michelle Ciucci; Kristin Gozdzikowska; Ester Hernández; Katherine Hutcheson; Corinne Jones; Julia Maclean; Nogah Nativ-Zeltzer; Emily Plowman; Nicole Rogus-Pulia; Nathalie Rommel; Ashli O'Rourke
Journal:  Dysphagia       Date:  2019-06-05       Impact factor: 3.438

7.  The clinical significance of esophagogastric junction outflow obstruction and hypercontractile esophagus in high resolution esophageal manometry.

Authors:  D Schupack; D A Katzka; D M Geno; K Ravi
Journal:  Neurogastroenterol Motil       Date:  2017-05-23       Impact factor: 3.598

8.  Jackhammer esophagus: Observations on a European cohort.

Authors:  T V K Herregods; A J P M Smout; J L S Ooi; D Sifrim; A J Bredenoord
Journal:  Neurogastroenterol Motil       Date:  2016-10-17       Impact factor: 3.598

9.  Jackhammer esophagus: Clinical presentation, manometric diagnosis, and therapeutic results-Results from a multicenter French cohort.

Authors:  Sara Philonenko; Sabine Roman; Frank Zerbib; Guillaume Gourcerol; Nathalie Gault; Alain Ropert; Stanislas Bruley des Varannes; Maximilien Barret; Veronique Vitton; Michel Bouchoucha; Nicolas Billar; Caroline Gorbatchef; Henri Duboc; Benoit Coffin
Journal:  Neurogastroenterol Motil       Date:  2020-06-08       Impact factor: 3.598

10.  High-Resolution Manometry Thresholds and Motor Patterns Among Asymptomatic Individuals.

Authors:  Arvind Rengarajan; Benjamin D Rogers; Zhiqin Wong; Salvatore Tolone; Daniel Sifrim; Jordi Serra; Edoardo Savarino; Sabine Roman; Jose M Remes-Troche; Rosa Ramos; Julio Perez de la Serna; Ans Pauwels; Ana Maria Leguizamo; Yeong Yeh Lee; Osamu Kawamura; Jamal Hayat; Albis Hani; Sutep Gonlachanvit; Daniel Cisternas; Dustin Carlson; Serhat Bor; Shobna Bhatia; Luiz Abrahao; John Pandolfino; C Prakash Gyawali
Journal:  Clin Gastroenterol Hepatol       Date:  2020-11-02       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.